HK1096395A1 - 2-(hetero)aryl-substituted tetrahydroquinoline derivatives - Google Patents

2-(hetero)aryl-substituted tetrahydroquinoline derivatives

Info

Publication number
HK1096395A1
HK1096395A1 HK07103564.3A HK07103564A HK1096395A1 HK 1096395 A1 HK1096395 A1 HK 1096395A1 HK 07103564 A HK07103564 A HK 07103564A HK 1096395 A1 HK1096395 A1 HK 1096395A1
Authority
HK
Hong Kong
Prior art keywords
hetero
aryl
tetrahydroquinoline derivatives
substituted tetrahydroquinoline
substituted
Prior art date
Application number
HK07103564.3A
Inventor
Kai Schiemann
Ulrich Emde
Dirk Finsinger
Johannes Gleitz
Helmut Reubold
Frank Zenke
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10360154A external-priority patent/DE10360154A1/en
Priority claimed from DE102004026026A external-priority patent/DE102004026026A1/en
Priority claimed from PCT/EP2004/014205 external-priority patent/WO2005063735A1/en
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1096395A1 publication Critical patent/HK1096395A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07103564.3A 2003-12-20 2007-04-03 2-(hetero)aryl-substituted tetrahydroquinoline derivatives HK1096395A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10360154A DE10360154A1 (en) 2003-12-20 2003-12-20 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
US53996104P 2004-01-30 2004-01-30
DE102004026026A DE102004026026A1 (en) 2004-05-27 2004-05-27 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
PCT/EP2004/014205 WO2005063735A1 (en) 2003-12-20 2004-12-14 2-(hetero)-aryl-substituted tetrahydroquinoline derivatives

Publications (1)

Publication Number Publication Date
HK1096395A1 true HK1096395A1 (en) 2007-06-01

Family

ID=34743228

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07103564.3A HK1096395A1 (en) 2003-12-20 2007-04-03 2-(hetero)aryl-substituted tetrahydroquinoline derivatives

Country Status (6)

Country Link
KR (1) KR101211973B1 (en)
AR (1) AR047068A1 (en)
CY (2) CY1110467T1 (en)
DE (1) DE502004008434D1 (en)
HK (1) HK1096395A1 (en)
MX (1) MXPA06006714A (en)

Also Published As

Publication number Publication date
MXPA06006714A (en) 2006-08-18
KR20060127002A (en) 2006-12-11
CY1111704T1 (en) 2015-10-07
KR101211973B1 (en) 2012-12-13
CY1110467T1 (en) 2015-04-29
DE502004008434D1 (en) 2008-12-18
AR047068A1 (en) 2006-01-04

Similar Documents

Publication Publication Date Title
ZA200603657B (en) Novel quinoline derivatives
HRP20041031A2 (en) Quinolinone derivatives
IL174654A0 (en) Alkoxy substituted imidazoquinolines
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
IL209082A0 (en) Fushed heterocyclic compounds
HK1088326A1 (en) Piperidine-benzenesulfonamide derivatives
GB0317665D0 (en) Qinazoline derivatives
PT1682493E (en) Amidoacetonitrile derivatives
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
PL1606277T3 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
PL376997A1 (en) Tetrahydroquinoline derivatives
PL377318A1 (en) Tetrahydroquinoline derivatives
PL1706373T3 (en) Amidoacetonitrile derivatives
HK1071364A1 (en) Quinoline derivatives
HK1085742A1 (en) Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
HK1096395A1 (en) 2-(hetero)aryl-substituted tetrahydroquinoline derivatives
GB2415431B (en) Thionucleoside S-nitrosyl derivatives
HK1077577A1 (en) Tetrahydroquinoline derivatives
GB0319148D0 (en) Azaquinazoline derivatives
AU2003280822A8 (en) Beauveriolide derivatives
GB0209993D0 (en) Heterocyclic derivatives
GB0209990D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: DELETION OF INVENTOR: ANZALI, SOHEILA; DROSDAT, HELGA; HOCK, BJOERN

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131214